Professional background

Dr. Alan Fayaz, MD(Res) MRCP FRCA FFPMRCA is a consultant in pain medicine, anaesthesia and perioperative care at UCLH, and honorary associate professor, University College London.

His clinical interests include the management of patients with neuropathic pain, pain relating to neurological disease and complex general pain.

Alan studied preclinical Medicine at the University of Cambridge and clinical medicine at Imperial College London. In 2012, the Faculty of Pain Medicine awarded him the Examination Prize, for achieving the top score at the FFPMRCA examination. He has also been awarded the Nuffield Gold Medal, from the Royal College of Anaesthetists, for performance in the primary FRCA examination.

In 2017 Alan obtained his doctorate in medical research from Imperial College London, after successfully submitting his thesis on pain epidemiology. His research outputs include a contemporaneous assessment of the prevalence of chronic pain phenotypes in the UK, published in the British Medical Journal. The article has been cited over 200 times since publication, and boasts a social media ‘altmetric’ score in the top 5% of all research outputs scored to date.

Alan is the acting media liaison for the British Pain Society; his remit is to raise public awareness of chronic pain, and to facilitate engagement between pain clinicians and patients/allied health professionals. He has strong links with undergraduate and postgraduate education. He has worked with the Faculty of Pain Medicine, and Mercy Ships to deliver EPM (Essentials of Pain Medicine) training to healthcare professionals in Africa, and to medical students and junior doctors in the United Kingdom, and is currently serving as the ‘Regional Lead’ for EPM in London.

He has completed a Generic Instructor Course, and subsequently taught on a number of Advance Life Support Courses in the UK.

Research interests

Chronic pain epidemiology, pain-risk stratification, neuropathic pain treatments, cannabis based medicinal products, opioid-light anaesthesia, chronic pain and cardiovascular diseases.

Languages spoken

Farsi, French


  • The Association Between Chronic Pain and Cardiac Disease: A Cross-sectional Population Study. Fayaz A, Watt HC, Langford RM, Donaldson LJ. The Clinical Journal of Pain. 2016;32(12):1062-8.
  • Assessing the relationship between chronic pain and cardiovascular disease: a systematic review and meta-analysis. Fayaz A, Ayis S, Panesar S, Langford RM, Donaldson LJ. Scandinavian Journal of Pain. 2016 Oct;13:76-90
  • Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. BMJ Open. 2016;6(6).
  • Integrating Research with Chronic Pain Training. A Fayaz. Transmitter Journal, p14 Autumn 2014. Report: Cervical Meningioma presenting with back pain; A Fayaz, S Nikolic. Journal of Observational Pain Medicine Vol. 1 No. 3 (2014) ISSN: 2047-0800
  • Physiotherapy after spinal injections; A Fayaz, K Ullrich. Pain News Vol. 11 No. 3 (2013) p185-187
  • Leadership development for early career doctors; CEM Coltart, R Cheung, A Ardolino et al. The Lancet Vol. 379 No. 9828 May 12, 2012 p1763-1850
  • Checking placement of nasogastric feeding tubes in adults: summary of a safety report from the NPSA; Lamont T, Beaumont C, A Fayaz et al. BMJ 2011.1022;342:d2586
  • Reporting and Learning from Close Calls. A Fayaz, L Morlock. Chapter 2 from the book ‘The value of Close Calls in Improving Patient Safety’ published under the Joint Commission resources, 2011, p13-24
  • Reducing the harm caused by misplaced nasogastric feeding tubes in adults, children and infants; National Patient Safety Agency: Patient Safety Alert 002; March 2011; Available at (Co-author and project lead)
  • Clinical Audit: Why it matters; A Fayaz. BMJ careers July 2010. Available at
  • Pauci-immune necrotizing and crescenteric glomerulonephritis in a patient with systemic lupus erythematosus; A Fayaz, Y Pirson, JP Cosyns et al. Clin Nephrology. 2008 Apr; 69(4):290-3
  • Neoadjuvant FEC chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer; W Heller, D Mazhar, R Ward et al. Oncology Rep. 2007 Jan;17(1):253-9 (Data Collection and Analysis)